These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34178652)

  • 21. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing.
    Ito M; Miyata Y; Hirano S; Kimura S; Irisuna F; Ikeda K; Kushitani K; Tsutani Y; Ueda D; Tsubokawa N; Takeshima Y; Okada M
    Oncotarget; 2017 Dec; 8(65):108936-108945. PubMed ID: 29312580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.
    Fasano M; Della Corte CM; Papaccio F; Ciardiello F; Morgillo F
    J Thorac Oncol; 2015 Aug; 10(8):1133-41. PubMed ID: 26039012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung.
    Moon JY; Choi SH; Kim TH; Lee J; Pyo JH; Kim YT; Lee SJ; Yoon HI; Cho J; Lee CG
    Radiat Oncol J; 2021 Dec; 39(4):288-296. PubMed ID: 34986550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.
    Grand B; Cazes A; Mordant P; Foucault C; Dujon A; Guillevin EF; Barthes FLP; Riquet M
    Lung Cancer; 2013 Sep; 81(3):404-409. PubMed ID: 23769675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving differential diagnosis of pulmonary large cell neuroendocrine carcinoma and small cell lung cancer via a transcriptomic, biological pathway-based machine learning model.
    Guo J; Hou L; Zhang W; Dong Z; Zhang L; Wu C
    Transl Oncol; 2021 Dec; 14(12):101222. PubMed ID: 34530194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of lung large cell neuroendocrine carcinoma.
    Lo Russo G; Pusceddu S; Proto C; Macerelli M; Signorelli D; Vitali M; Ganzinelli M; Gallucci R; Zilembo N; Platania M; Buzzoni R; de Braud F; Garassino MC
    Tumour Biol; 2016 Jun; 37(6):7047-57. PubMed ID: 26943800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancer.
    Igawa S; Watanabe R; Ito I; Murakami H; Takahashi T; Nakamura Y; Tsuya A; Kaira K; Naito T; Endo M; Yamamoto N; Kameya T
    Lung Cancer; 2010 Jun; 68(3):438-45. PubMed ID: 19699548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities.
    Ferrara MG; Stefani A; Simbolo M; Pilotto S; Martini M; Lococo F; Vita E; Chiappetta M; Cancellieri A; D'Argento E; Trisolini R; Rindi G; Scarpa A; Margaritora S; Milella M; Tortora G; Bria E
    Front Oncol; 2021; 11():650293. PubMed ID: 33937057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
    Derks JL; Hendriks LE; Buikhuisen WA; Groen HJ; Thunnissen E; van Suylen RJ; Houben R; Damhuis RA; Speel EJ; Dingemans AM
    Eur Respir J; 2016 Feb; 47(2):615-24. PubMed ID: 26541538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes for localized treatment of large cell neuroendocrine carcinoma of the lung in the United States.
    May MS; Kinslow CJ; Adams C; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
    Transl Lung Cancer Res; 2021 Jan; 10(1):71-79. PubMed ID: 33569294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype.
    Hermans BCM; Derks JL; Groen HJM; Stigt JA; van Suylen RJ; Hillen LM; van den Broek EC; Speel EJM; Dingemans AC
    Endocr Connect; 2019 Dec; 8(12):1600-1606. PubMed ID: 31751303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
    Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
    [No Abstract]   [Full Text] [Related]  

  • 36. The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung.
    Buium C; Negru S; Ionescu DN; Dediu M
    Curr Oncol; 2023 Jul; 30(8):7218-7228. PubMed ID: 37623004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
    Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
    Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
    Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
    Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
    Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
    J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Expression Profiling of Large Cell Lung Cancer Links Transcriptional Phenotypes to the New Histological WHO 2015 Classification.
    Karlsson A; Brunnström H; Micke P; Veerla S; Mattsson J; La Fleur L; Botling J; Jönsson M; Reuterswärd C; Planck M; Staaf J
    J Thorac Oncol; 2017 Aug; 12(8):1257-1267. PubMed ID: 28535939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.